234 related articles for article (PubMed ID: 33741764)
41. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
[TBL] [Abstract][Full Text] [Related]
42. Undifferentiated component of dedifferentiated endometrial carcinoma presenting as a "small round cell" malignancy in a mediastinal lymph node, mimicking small cell carcinoma.
Balikani L; Policarpio-Nicolas MLC
Diagn Cytopathol; 2023 Aug; 51(8):519-524. PubMed ID: 37318779
[TBL] [Abstract][Full Text] [Related]
43. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
[TBL] [Abstract][Full Text] [Related]
44. Androgen Receptor Immunohistochemical Expression in Undifferentiated/Dedifferentiated Endometrial Carcinoma.
Cao J; Hacking S; Chavarria-Bernal HD; Bhuiya TA; Khutti S
Int J Gynecol Pathol; 2022 Jan; 41(1):28-34. PubMed ID: 33399351
[TBL] [Abstract][Full Text] [Related]
45. Dedifferentiated carcinoma with clear cell carcinoma of the endometrium: A case report.
Lee SE; Park HY; Shim SH; Kim WY
Pathol Int; 2017 Sep; 67(9):472-476. PubMed ID: 28667682
[TBL] [Abstract][Full Text] [Related]
46. Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma.
Mao TL; Ardighieri L; Ayhan A; Kuo KT; Wu CH; Wang TL; Shih IeM
Am J Surg Pathol; 2013 Sep; 37(9):1342-8. PubMed ID: 24076775
[TBL] [Abstract][Full Text] [Related]
47. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484
[TBL] [Abstract][Full Text] [Related]
48. Tumor-to-tumor metastasis with endometrial carcinoma metastatic to squamous cell carcinoma of vulva: the first reported case.
Wimmer JL; Coffey DM; Kaplan AL; Ayala AG; Ro JY
Arch Pathol Lab Med; 2013 Dec; 137(12):1825-8. PubMed ID: 24283863
[TBL] [Abstract][Full Text] [Related]
49. FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
Weisman P; Park KJ; Xu J
Int J Gynecol Pathol; 2022 Mar; 41(2):126-131. PubMed ID: 33811207
[TBL] [Abstract][Full Text] [Related]
50. Role of Immunohistochemistry to Distinguish Grade 3 Endometrioid Carcinoma and Uterine Serous Carcinoma.
Zaidi A; Gupta P; Gupta N; Rajwanshi A; Rai B; Gainder S
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):42-48. PubMed ID: 31815745
[TBL] [Abstract][Full Text] [Related]
51. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.
Clarke BA; Gilks CB
J Clin Pathol; 2010 May; 63(5):410-5. PubMed ID: 20418232
[TBL] [Abstract][Full Text] [Related]
52. Endometrial Endometrioid Carcinoma With Ovarian Metastasis Showing Morula-like Features in a Patient With Cowden Syndrome: A Case Report.
Kuno I; Tate K; Yoshida H; Takahashi K; Kato T
Int J Gynecol Pathol; 2020 Jan; 39(1):36-42. PubMed ID: 30676432
[TBL] [Abstract][Full Text] [Related]
53. Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients.
Kato MK; Yoshida H; Tanase Y; Uno M; Ishikawa M; Kato T
Pathol Oncol Res; 2021; 27():598550. PubMed ID: 34257552
[No Abstract] [Full Text] [Related]
54. Small Cell Neuroendocrine Carcinoma of the Endometrium with Difficulty Identifying the Original Site in the Uterus.
Iida T; Muramatsu T; Kajiwara H; Kato N; Itoh H; Narayama T; Machida H; Ikeda M; Shida M; Hirasawa T; Mikami M
Tokai J Exp Clin Med; 2020 Dec; 45(4):156-161. PubMed ID: 33300584
[TBL] [Abstract][Full Text] [Related]
55. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
56. Axillary mass suspected to be occult breast carcinoma: a case study of skipped axillary lymph node metastasis from endometrial carcinoma in which core-needle biopsy was useful for diagnosis.
Sanuki J; Uchida Y; Uematsu T; Yamada Y; Kasami M
Breast Cancer; 2009; 16(1):72-6. PubMed ID: 18465195
[TBL] [Abstract][Full Text] [Related]
57. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?
Silva EG; Deavers MT; Bodurka DC; Malpica A
Int J Gynecol Pathol; 2006 Jan; 25(1):52-8. PubMed ID: 16306785
[TBL] [Abstract][Full Text] [Related]
58. Isolated Diaphragmatic Metastasis Originating From Early Endometrial Cancer.
Okada S; Miyagawa-Hayashino A; Sonobe Y; Inoue M
Ann Thorac Surg; 2020 Jul; 110(1):e27-e29. PubMed ID: 31978375
[TBL] [Abstract][Full Text] [Related]
59. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
Rubatt JM; Slomovitz BM; Burke TW; Broaddus RR
Gynecol Oncol; 2005 Nov; 99(2):472-6. PubMed ID: 16099019
[TBL] [Abstract][Full Text] [Related]
60. Evanescence of Endometrial Carcinomas in Hysterectomy Specimens: Observations on the "Vanishing Cancer" Phenomenon.
Bharani V; Rai B; Rajwanshi A; Gupta N; Dey P; Kalra J; Suri V; Srinivasan R
Int J Surg Pathol; 2019 Feb; 27(1):43-47. PubMed ID: 29944030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]